These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10911024)

  • 1. Conformational and topographical considerations in designing agonist peptidomimetics from peptide leads.
    Hruby VJ; Balse PM
    Curr Med Chem; 2000 Sep; 7(9):945-70. PubMed ID: 10911024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of peptides, proteins, and peptidomimetics in chi space.
    Hruby VJ; Li G; Haskell-Luevano C; Shenderovich M
    Biopolymers; 1997; 43(3):219-66. PubMed ID: 9277134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-Ala containing peptides: potentials in design and construction of bioactive peptides and protein secondary structure mimics.
    Kishore R
    Curr Protein Pept Sci; 2004 Dec; 5(6):435-55. PubMed ID: 15581415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side Chain Cyclized Aromatic Amino Acids: Great Tools as Local Constraints in Peptide and Peptidomimetic Design.
    Van der Poorten O; Knuhtsen A; Sejer Pedersen D; Ballet S; Tourwé D
    J Med Chem; 2016 Dec; 59(24):10865-10890. PubMed ID: 27690430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal complexes of chiral pentaazacrowns as conformational templates for beta-turn recognition.
    Reaka AJ; Ho CM; Marshall GR
    J Comput Aided Mol Des; 2002; 16(8-9):585-600. PubMed ID: 12602952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design considerations and computer modeling related to the development of molecular scaffolds and peptide mimetics for combinatorial chemistry.
    Hruby VJ; Shenderovich M; Lam KS; Lebl M
    Mol Divers; 1996 Oct; 2(1-2):46-56. PubMed ID: 9238633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A three-dimensional model of the delta-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands.
    Shenderovich MD; Liao S; Qian X; Hruby VJ
    Biopolymers; 2000 Jun; 53(7):565-80. PubMed ID: 10766952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design criteria for molecular mimics of fragments of the beta-turn. 1. C alpha atom analysis.
    Garland SL; Dean PM
    J Comput Aided Mol Des; 1999 Sep; 13(5):469-83. PubMed ID: 10483529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design in topographical space of peptide and peptidomimetic ligands that affect behavior. A chemist's glimpse at the mind--body problem.
    Hruby VJ
    Acc Chem Res; 2001 May; 34(5):389-97. PubMed ID: 11352717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of peptide and peptidomimetic ligands with novel pharmacological activity profiles.
    Hruby VJ; Cai M
    Annu Rev Pharmacol Toxicol; 2013; 53():557-80. PubMed ID: 23294313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azapeptide Synthesis Methods for Expanding Side-Chain Diversity for Biomedical Applications.
    Chingle R; Proulx C; Lubell WD
    Acc Chem Res; 2017 Jul; 50(7):1541-1556. PubMed ID: 28598597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topochemical design of bioactive peptides and peptidomimetics.
    Goodman M; Ro S; Yamazaki T; Spencer JR; Toy A; Huang Z; He Y; Reisine T
    Bioorg Khim; 1992; 18(10-11):1375-93. PubMed ID: 1363715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Asymmetric Synthesis Protocol to Prepare Topographically Constrained β-Substituted Aromatic Amino Acids.
    Liao S; Hruby VJ
    Methods Mol Med; 1999; 23():175-87. PubMed ID: 21380898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and evaluation of matrix metalloprotease inhibitors bearing cyclopropane-derived peptidomimetics as P1' and P2' replacements.
    Reichelt A; Gaul C; Frey RR; Kennedy A; Martin SF
    J Org Chem; 2002 Jun; 67(12):4062-75. PubMed ID: 12054939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational and topographical considerations in the design of biologically active peptides.
    Hruby VJ
    Biopolymers; 1993 Jul; 33(7):1073-82. PubMed ID: 8102072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing molecules: specific peptides for specific receptors.
    Hruby VJ
    Epilepsia; 1989; 30 Suppl 1():S42-50; discussion S64-8. PubMed ID: 2570689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclopropane-Based Peptidomimetics Mimicking Wide-Ranging Secondary Structures of Peptides: Conformational Analysis and Their Use in Rational Ligand Optimization.
    Mizuno A; Kameda T; Kuwahara T; Endoh H; Ito Y; Yamada S; Hasegawa K; Yamano A; Watanabe M; Arisawa M; Shuto S
    Chemistry; 2017 Mar; 23(13):3159-3168. PubMed ID: 28000361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin Ligands with α/β-Hybrid Peptide Structure: Design, Bioactivity, and Conformational Aspects.
    De Marco R; Tolomelli A; Juaristi E; Gentilucci L
    Med Res Rev; 2016 May; 36(3):389-424. PubMed ID: 26777675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor.
    Liao S; Alfaro-Lopez J; Shenderovich MD; Hosohata K; Lin J; Li X; Stropova D; Davis P; Jernigan KA; Porreca F; Yamamura HI; Hruby VJ
    J Med Chem; 1998 Nov; 41(24):4767-76. PubMed ID: 9822547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformation-activity relationships of opioid peptides with selective activities at opioid receptors.
    Hruby VJ; Agnes RS
    Biopolymers; 1999; 51(6):391-410. PubMed ID: 10797229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.